The dynamics of the COVID-19 pandemic, including multi-country shutdowns, put an excessive amount of pressure on healthcare supply chains worldwide. There are clear signs that the pandemic will be here in the long run, driving healthcare companies to address supply chain vulnerabilities. Pharmaceutical companies relied heavily on an unprecedented level of cooperation from raw material suppliers, government agencies, and contract development and manufacturing organizations.
Listen to others' experiences, participate in a live, interactive question-and-answer session, and walk away with actionable strategies for your organization.
Attend this webinar to discover:
• How the unquestionable impact of these shifts results from three merging drivers of change—coordinated management, flexible manufacturing strategies, and seamless mobility.
• Best practices to optimize supply chain networks.
• Direct-to-patient (DTP) and home care business models.
• New strategies for the medical device and pharmaceutical industries.
• Growth opportunities in a post-COVID-19 environment.
• Medical device track-and-trace solutions and re-shoring hubs.
• Cold chain capabilities for next-generation vaccines and biologics.
• Valuable insights on real-time inventory management.